Stay updated on Sasanlimab in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.

Latest updates to the Sasanlimab in Advanced Malignancies Clinical Trial page
- CheckyesterdayChange DetectedThe study record now indicates a Completed status and an expanded network of 49 locations. A new site in Dnipro, Ukraine has been added, and the city name for an existing location has been updated to Kropyvnytskyi (formerly Kirovohrad).SummaryDifference0.5%

- Check8 days agoChange DetectedRecruitment status now indicates enrollment is closed. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label and revision note to v3.6.0.SummaryDifference0.3%

- Check15 days agoChange DetectedThe page's Revision label was updated from v3.5.4 to v3.5.5.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page revision tag was updated to v3.5.4, signaling a new release for the page. There are no detected user-facing content changes associated with this update.SummaryDifference0.0%

- Check51 days agoChange DetectedThree new update dates were added to the study record's history in April 2026, and three older update dates from February and March 2026 were removed. The changes reflect administrative updates to the record rather than alterations to the study design, eligibility criteria, or results.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a maintenance or technical release without altering the displayed clinical study information.SummaryDifference0.0%

Stay in the know with updates to Sasanlimab in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Advanced Malignancies Clinical Trial page.